Cephalexin-induced acute generalized exanthematous pustulosis | Zendy

Matthew DaCunha | Zendy; Sarah Moore | Zendy; David L. Kaplan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cephalexin-induced acute generalized exanthematous pustulosis

Author(s) -

Matthew DaCunha,

Sarah Moore,

David L. Kaplan

Publication year - 2018

Publication title -

dermatology reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.183

H-Index - 10

eISSN - 2036-7406

pISSN - 2036-7392

DOI - 10.4081/dr.2018.7686

Subject(s) - acute generalized exanthematous pustulosis , medicine , cephalosporin , dermatology , antibiotics , drug reaction , cephalosporin antibiotic , intensive care medicine , drug , pharmacology , microbiology and biotechnology , biology

Cephalexin is a cephalosporin antibiotic that is commonly used in the treatment of infectious diseases. We report a patient exhibiting a rare adverse effect of cephalexin: drug-induced Acute Generalized Exanthematous Pustulosis (AGEP). We present this case because of the scarcity of reports associating cephalexin with AGEP in hopes that clinicians will consider AGEP in their differential diagnosis in the appropriate clinical setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research